Rosenberg Ellen

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$230,100.00
Insider Sells Quantity
12
Insider Sells Sum
$3.32M

Insider Activity of Rosenberg Ellen

According to the SEC Form 4 filings, Rosenberg Ellen, being in a position of

  1. Chief Legal Officer at Amicus Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 95000 shares for $1.31M,
    over all time since 2016-06-02, has bought 30000 shares for $230,100, and sold 285198 shares for $3.32M.

The largest purchase of all time was on 2016-06-02 and amounted to 30000 shares of Amicus Therapeutics, Inc. for $230,100.

The largest sale of all time was on 2020-07-16 and amounted to 60000 shares of Amicus Therapeutics, Inc. for $612,711.

Biography of Rosenberg Ellen

No biography is available at this moment.

2024-02-07SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
29,600
0.0104%
$13.00$384,818-16.69%
2024-02-06SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
400
0.0001%
$13.00$5,200-16.49%
2024-01-02SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
30,000
0.0102%
$14.21$426,219-20.61%
2023-12-27SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
5,000
0.0017%
$14.07$70,327-21.66%
2023-12-26SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
30,000
0.0102%
$14.00$420,084-19.79%
2023-01-24SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
31,839
0.0109%
$13.32$424,006-8.85%
2022-08-01SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
11,123
0.0039%
$10.02$111,472+19.86%
2022-06-21SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
11,122
0.0039%
$10.00$111,272+16.3%
2022-04-07SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
11,018
0.0038%
$9.06$99,797+22.92%
2020-07-16SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
60,000
0.0154%
$10.21$612,711-8.33%
2020-01-15SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
44,200
0.0171%
$10.35$457,284+35.51%
2020-01-02SaleAmicus Therapeutics, Inc.
FOLD
Chief Legal Officer
20,896
0.0081%
$9.56$199,768+44.5%
2016-06-02PurchaseAmicus Therapeutics, Inc.
FOLD
General Counsel & Corp. Secy
30,000
0.0231%
$7.67$230,100-10.12%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.